Navigation Links
Aethlon Medical (AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor
Date:10/24/2013

molecules. Consequently, the ability of the Hemopurifier® to remove these circulating exosomes may provide a superior approach to treat these patients without the generalized inhibition of the respective molecular pathways.  

About Aethlon Medical, Inc.

Aethlon Medical creates innovative medical devices to address life-threatening diseases. The Aethlon ADAPT™ (Adaptive Dialysis-like Affinity Platform Technology) establishes the basis for a new class of therapeutics that target the rapid elimination of disease enabling particles from the circulatory system of treated patients.  The lead Aethlon ADAPT™ product is the Hemopurifier®, a device that addresses a broad-spectrum of viral pathogens as well as tumor-secreted exosomes that suppress the immune system of cancer patients.  Aethlon is also operating under two government contracts with the Defense Advanced Research Projects Agency (DARPA) related the development of a medical device to reduce the incidence of sepsis. Exosome Sciences, Inc. is a majority owned Aethlon subsidiary that is advancing exosome-based strategies to diagnose and monitor cancer and infectious disease progression.  Additional information can be found at www.AethlonMedical.com

Certain statements herein may be forward-looking and involve risks and uncertainties.  Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Aethlon Medical Announces the Appointment of Dr. Cicek Gercel-Taylor as Clinical Research Director of Exosome Sciences, Inc.
2. Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
3. Aethlon Medical Announces Launch of Exosome Sciences Subsidiary
4. Aethlon Medical to Present at Exosomes and Circulating Biomarkers 2013 Summit
5. Aethlon Medical Announces the Appointment of Chetan S. Shah, M.D. to its Board of Directors
6. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
7. Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama
8. Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer
9. Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Aethlon Medical (AEMD) Note: Since September 30th, 2011 / Thank You Shareholders
11. Aethlon Medical Discloses CEO Interview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... of units of common stock and warrants at a ... $20 million, prior to deducting underwriting discounts and commissions ... and warrants are immediately separable and will be issued ... begin trading on The NASDAQ Stock Market under the ...
(Date:8/21/2014)... 2014 Nektar Therapeutics (NASDAQ: ... positive results from its Phase 3 pivotal clinical ... recombinant factor VIII (rFVIII) treatment for hemophilia A ... its primary endpoint in reducing annualized bleed rates ... on-demand arm. Top-line results from the ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... 16 After more than 10 years of research and ... of a new company to build and market a breast ... as C.U.R.E. (Computerized Ultrasound Risk Evaluation), now referred to as ... Delphinus Medical Technologies, LLC. The company has already secured sale ...
... SAN DIEGO, Nov. 16 CareFusion (NYSE: ... announced a Web-based application that provides hospitals with on-demand ... costs. , The CareFusion Knowledge Portal is a remotely ... information dashboard to review metrics and actionable data directly ...
Cached Medicine Technology:Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 2Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 4Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 5CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 2CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 3
(Date:8/22/2014)... 22, 2014 With the stage set ... Total Store Expo - which will be held in ... pro-pharmacy op-ed in its online opinion section, Podium. ... ” is co-authored by Steven C. Anderson, IOM, CAE, ... dean of the MCPHS University School of Pharmacy – ...
(Date:8/22/2014)... The regional economy is about to ... on the grow again. The plant will invest ... to boost production of the popular Highlander midsize sport ... investment to $4 billion. This step allows Toyota to ... flexibility to adjust its product mix to meet changing ...
(Date:8/22/2014)... (HealthDay News) -- Many Americans know little about how Ebola ... an outbreak in the United States, a new survey shows. ... that there will be a major Ebola outbreak in the ... immediate family member will get sick with the deadly virus ... of Public Health poll. However, those opinions don,t match ...
(Date:8/22/2014)... 2014 Beat Eczema , Susan ... use natural methods to completely cure the eczema symptoms ... of Shane Michaels, prompting an investigative review. , ... skin, it can still be extremely debilitating and life-altering ... intense itching and pain that it causes on the ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in the ... advanced non-small cell lung cancer (NSCLC) patients correlates well ... , EGFR tyrosine kinase inhibitor (TKI) therapy is approved ... but the standard for determining mutation status is with ... limited or not available. A more abundant and less ...
Breaking Medicine News(10 mins):Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2
... European Society for Medical Oncology is proud to announce ... their commitment to providing excellent palliative care as part ... prestigious "ESMO Designated Centers of Integrated Oncology and Palliative ... comprehensive services in supportive and palliative care. The ...
... The SwitchTM programme, ,Switch what you Do, View, and Chew, ... and vegetable consumption and lowering ,screen time,. Researchers writing in ... programme and report that it offers promise for use in ... Iowa State University, USA, worked with a team of researchers ...
... , , FRIENDSWOOD, Texas, Sept. ... which develops, manages and owns faith-based senior living facilities, today ... lender for the development of a new senior living facility ... an 82-unit, $10 million senior living facility should be available ...
... WESTFORD, Mass., Sept. 22 Cynosure, Inc. (Nasdaq: CYNO ... light-based aesthetic treatment systems, today announced that President and Chief Executive ... at the third annual Maxim Group Growth Conference in New York ... webcast live over the Internet beginning at 10:00 a.m. (ET) Tuesday, ...
... to exaggerated fears as the real threat , TUESDAY, Sept. ... dire predictions and hastily ordered vaccines, could the growing worry ... outbreak? , That notion is weighing on the minds of ... winter flu season looms. , Not only does societal panic ...
... , RADNOR, Pa., Sept. 22 Eric Hipple, ... Feeling Blue Suicide Prevention Council,s Swing into Life! Golf Tournament, Wednesday, ... former National Football League (NFL) quarterback whose ten year career was ... a divisional championship, and the most valuable NFL player award for ...
Cached Medicine News:Health News:ESMO recognizes centers of excellence in palliative care for cancer patients 2Health News:Switch program increases kids' healthy eating, reduces screen time 2Health News:TrinityCare Senior Living Announces Expansion into Louisiana 2Health News:TrinityCare Senior Living Announces Expansion into Louisiana 3Health News:Cynosure to Present at the Maxim Group Growth Conference 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 3Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 4Health News:Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: